EUVIMEDAtrasti EUVIMED
Crossref

Design, Synthesis, and Evaluation of Novel Syncarpic Acid Derivatives as Potential Anti‐Inflammatory Agents

Revoju Sravanthi, Vaishnavi Kambhampati, Abhisheik Eedara, Sai Balaji Andugulapati iD, Dhevalapally B Ramachary iD

ChemMedChem · 2026-05-14 · 21 (9)

DOI: 10.1002/cmdc.70306 ↗

At a glance

Journal article in ChemMedChem, published online on 2026-05-14. Written by Revoju Sravanthi and 4 co-authors. Institution: Catalysis Laboratory, School of Chemistry, University of Hyderabad, Hyderabad, India. Major MEDLINE topics: Drug Design, Anti-Inflammatory Agents, Non-Steroidal, Antioxidants, Anti-Inflammatory Agents. 39 references. Funded by: Department of Science and Technology, Ministry of Science and Technology, India.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Inflammation is a complex immune response driven by oxidative stress and proinflammatory mediators that promote tissue damage and disease progression. Although syncarpic acid exhibits antioxidant therapeutic potential, its clinical utility is limited by suboptimal efficacy and poor pharmacological properties. In the current study, we synthesized novel 4‐alkyl/aryl‐syncarpic acid derivatives using organocatalytic reductive C ‐alkylation and Rh‐catalyzed α ‐arylation of cyclic iodonium ylides, achieving yields ranging from good to excellent. Furthermore, the antioxidant and anti‐inflammatory potential of these compounds was evaluated using the DPPH radical scavenging assay, DCFDA assay, RT‐qPCR, and Western blot analysis in RAW 264.7 and BEAS‐2B cell lines. Our findings demonstrated that compounds 5c and 9a exhibited markedly higher antioxidant and anti‐inflammatory activity compared to other syncarpic acid derivatives. Western blot analysis further revealed that compounds 5c and 9a exert their anti‐inflammatory effects, at least in part, by modulating the MAPK signaling pathway. Acute toxicity studies indicate that compound 9a exhibits a favorable safety profile while retaining significant antioxidant activity. Overall, these results indicated that the syncarpic acid derivatives 5c and 9a exhibit potent anti‐inflammatory efficacy and acceptable safety margins, supporting their potential therapeutic application in inflammatory disorders such as acute respiratory distress syndrome (ARDS) and ulcerative colitis.

Subjects

MeSH terms (MEDLINE)

Drug DesignAnti-Inflammatory Agents, Non-SteroidalAntioxidantsAnti-Inflammatory AgentsAnimalsMiceHumansStructure-Activity RelationshipRAW 264.7 CellsMolecular StructureCell LineDose-Response Relationship, DrugCell SurvivalBiphenyl Compounds

Author keywords

antioxidantschemokinescytokinesinflammationreductive alkylationsyncarpic acid

Substances

Anti-Inflammatory Agents, Non-SteroidalAntioxidantsAnti-Inflammatory AgentsBiphenyl Compounds

Authors and institutions

  • Catalysis Laboratory, School of Chemistry, University of Hyderabad, Hyderabad, India.
  • Department of Pharmaceutical Chemistry, GITAM School of Pharmacy, GITAM (Deemed to be University), Visakhapatnam, India.
  • Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Hyderabad, Telangana, India.

ORCID profiles: Sai Balaji Andugulapati, Dhevalapally B Ramachary

Funding

  • Department of Science and Technology, Ministry of Science and Technology, India

Cite

APA

Sravanthi, R., Kambhampati, V., Eedara, A., Andugulapati, S. B., & Ramachary, D. B. (2026). Design, Synthesis, and Evaluation of Novel Syncarpic Acid Derivatives as Potential Anti‐Inflammatory Agents. ChemMedChem, 21(9). https://doi.org/10.1002/cmdc.70306

Vancouver

Sravanthi R, Kambhampati V, Eedara A, Andugulapati SB, Ramachary DB. Design, Synthesis, and Evaluation of Novel Syncarpic Acid Derivatives as Potential Anti‐Inflammatory Agents. ChemMedChem. 2026;21(9). doi:10.1002/cmdc.70306

BibTeX
@article{Sravanthi2026,
  author = {Sravanthi, Revoju and Kambhampati, Vaishnavi and Eedara, Abhisheik and Andugulapati, Sai Balaji and Ramachary, Dhevalapally B},
  title = {Design, Synthesis, and Evaluation of Novel Syncarpic Acid Derivatives as Potential Anti‐Inflammatory Agents},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {9},
  doi = {10.1002/cmdc.70306}
}
Start for free →